Home Tags Cancer: Prostate

Tag: Cancer: Prostate

Prostate-Specific Antigen Levels Posttreatment May Not Predict Overall Survival

Biochemical recurrence does not meet the criteria to be a reliable surrogate endpoint for overall survival

Common Cancer Screenings May Not Extend Life Longevity

Meta-analysis only shows a 110-day survival benefit for colorectal cancer screening with sigmoidoscopy

Prostate MRI Has Independent Screening Value

In a recent study, 16 percent of men who responded to screening invite had positive screening MRI

FDA Approves Akeega for BRCA-Positive Metastatic Prostate Cancer

Akeega plus prednisone significantly improves radiographic progression-free survival in patients with castration-resistant prostate cancer

Care at High-Volume Radiation Treatment Centers Tied to Higher Survival

Findings seen among men with very high-risk prostate cancer

Survival Similar for Black, White Prostate Cancer Patients in Clinical Trial Setting

Median PFS, OS similar for Black and White patients receiving first- or second-generation androgen receptor pathway inhibitors

PSMA-PET Improves Prediction of Biochemical Recurrence in Prostate Cancer

Risk assessment for biochemical recurrence improved with addition of PSMA PET N1/M1 status to presurgical Cancer of the Prostate Risk Assessment score

Toxicity Reduced With MRI-Guided Radiotherapy for Prostate Cancer

Odds ratios for acute grade 2 or higher genitourinary and gastrointestinal toxicities reduced for MRg-A-SBRT versus CT-SBRT

For Prostate Cancer Info Videos, Patients Prefer Hearing From a Physician

And, racial concordance between patient and physician important for trust among Black adults

Indigenous Men Less Likely to Receive PSA Testing

Indigenous men with prostate cancer are also more likely to have higher-risk disease characteristics